Castleview Partners, LLC Pfizer Inc Transaction History

Castleview Partners, LLC

$145 Million
Q4 2025

A detailed history of Castleview Partners, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Castleview Partners, LLC holds 13,495 shares of PFE stock, worth $338,454. This represents 0.23% of its overall portfolio holdings.

Number of Shares

13,495

Previous 11,173 20.78%

Holding current value

$338,454

Previous $284,000 19.01%

% of portfolio

0.23%

Previous 0.23%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2025 Jan 12, 2026	BUY	$24.23 - $27.37 $56,262 - $63,553	2,322 Added 20.78%	13,495 $338,000
Q3 2025 Oct 10, 2025	BUY	$23.29 - $25.88 $44,157 - $49,068	1,896 Added 20.44%	11,173 $284,000
Q2 2025 Jul 15, 2025	BUY	$21.59 - $24.84 $820 - $943	38 Added 0.41%	9,277 $224,000
Q1 2025 Apr 21, 2025	BUY	$25.01 - $27.13 $925 - $1,003	37 Added 0.4%	9,239 $234,000
Q4 2024 Jan 21, 2025	BUY	$24.8 - $30.19 $26,932 - $32,786	1,086 Added 13.38%	9,202 $244,000

Q3 2024 Oct 21, 2024	BUY	$27.7 - $31.39 $2,742 - $3,107	99 Added 1.23%	8,116 $234,000
Q2 2024 Jul 31, 2024	BUY	$25.26 - $29.6 $34,151 - $40,019	1,352 Added 20.29%	8,017 $224,000
Q1 2024 May 09, 2024	BUY	$25.89 - $29.73 $46,239 - $53,097	1,786 Added 36.61%	6,665 $184,000
Q4 2023 Feb 05, 2024	BUY	$26.13 - $33.94 $42,800 - $55,593	1,638 Added 50.54%	4,879 $140,000
Q3 2023 Oct 26, 2023	SELL	$32.09 - $37.51 $169,018 - $197,565	-5,267 Reduced 61.91%	3,241 $107,000
Q2 2023 Aug 14, 2023	SELL	$36.12 - $41.79 $133,607 - $154,581	-3,699 Reduced 30.3%	8,508 $312,000
Q1 2023 May 15, 2023	BUY	$39.39 - $51.28 $11,304 - $14,717	287 Added 2.41%	12,207 $498,000
Q4 2022 Feb 01, 2023	SELL	$41.75 - $54.5 $22,879 - $29,866	-548 Reduced 4.4%	11,920 $611,000
Q3 2022 Nov 10, 2022	BUY	$43.76 - $53.42 $462,805 - $564,969	10,576 Added 558.99%	12,468 $546,000
Q2 2022 Aug 17, 2022	SELL	$46.53 - $55.17 $32.7 Million - $38.8 Million	-703,763 Reduced 99.73%	1,892 $99,000
Q2 2022 Aug 16, 2022	BUY	$46.53 - $55.17 $32.1 Million - $38 Million	689,348 Added 4227.31%	705,655 $37 Million
Q1 2022 May 16, 2022	SELL	$45.75 - $56.69 $41.3 Million - $51.2 Million	-902,933 Reduced 98.23%	16,307 $844,000
Q4 2021 Feb 17, 2022	BUY	$41.32 - $61.25 $37.3 Million - $55.3 Million	903,129 Added 5605.67%	919,240 $54.3 Million
Q2 2021 Aug 17, 2021	SELL	$35.91 - $40.68 $249,610 - $282,766	-6,951 Reduced 30.14%	16,111 $631,000
Q1 2018 May 07, 2018	BUY	$31.91 - $37.02 $735,908 - $853,755	23,062 New	23,062 $818,000

Others Institutions Holding PFE

# of Institutions

3,367

Shares Held

3.57B

Call Options Held

86.1M

Put Options Held

105M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $141B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Castleview Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Castleview Partners, LLC with notifications on news.

Account

Castleview Partners, LLC Pfizer Inc Transaction History